Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Eiger BioPharmaceuticals
company
Funding Round
Post-IPO Debt
Money Raised
$ 75M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| Innovatus Capital Partners | - | Yes | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Feb 25, 2009 | Series A | $ 8.30M | InterWest Partners,Vivo Capital | Detail |
| Nov 23, 2015 | Debt Financing | $ 6M | Detail | |
| Apr 15, 2011 | Series A | $ 14.46M | InterWest Partners,Vivo Capital | Detail |
| Oct 26, 2017 | Post-IPO Equity | $ 19.50M | Detail | |
| Jan 1, 2007 | Seed | 0 | RA Capital Management | Detail |
| Jan 4, 2017 | Post-IPO Debt | $ 25M | Oxford Finance LLC | Detail |
| Apr 29, 2016 | Post-IPO Equity | $ 2.99M | Detail | |
| Mar 21, 2016 | Debt Financing | 0 | InterWest Partners | Detail |
| Mar 23, 2016 | IPO | 0 | Detail |
